Rethinking diffusion of vaccines: giving healthcare a better shot
Schlagworte:
Innovation Systems, Diffusion, VaccinesAbstract
Vaccination is an area of rapid scientific and technological advance and is among the most successful public health interventions ever. However, for its potential to be met, innovation systems should not only make vaccines available: it is also essential that delivery systems suit social desires and local peculiarities. This work presents 2 cases of failures in diffusing vaccines, as social, cultural and political aspects were not well addressed throughout the campaigns. Lessons taken from these cases suggest that instead of focusing merely on increasing immunity, policies should integrate interdisciplinary bodies of knowledge and promote social engagement through bottom-up processes. These approaches are not only keener on improving acceptability and efficacy in delivering existing technologies, but also to create (and adapt) novelties based on local capabilities.
Literaturhinweise
ACERO, L; SAVAGET, P (2011). As pesquisas e terapias com células-tronco no Brasil: as perspectivas de diferentes grupos sociais sobre o progresso cientifico e técnico e os conhecimentos especializados e leigos. Revista Brasileira de Ciência, Tecnologia e Sociedade, v.2, n.2, p.100-129.
ACHEBE, c. (2004). The polio epidemic in Nigeria: A public health emergency (14 July). Available at: http://www.nigeriavillagesquare1.com/ Articles/CCAchebe4.htm
ALBUQUERQUE, e (1997). Notas sobre os determinantes tecnológicos do catching-up: uma introdução à discussão sobre o papel dos sistemas nacionais de inovação na periferia. Estudos econômicos, São Paulo, v. 27, n. 2, p. 221-253, mai/ago, 1997.
ARTHUR, W (1988). Competing technologies. In: Dosi, G., Freeman, C., Nelson, R., Silverberg, G., Soete, L. _Eds..,Technical Change and Economic Theory. Pinter, London, pp. 590–607.
BERKHOUT, F; MACKERRON, g (2009). Learning to listen: institutional change and legitimation in UK radioactive waste policy, Journal of Risk Research 12 (7&8) pp. 989-1008.
BLUME, S (2006). Anti-vaccination movements and their interpretations. Social Science & Medicine vol.62, p.628–642.
BURGESS, D., BURGESS, M., LEASK, M (2006). The MMR vaccination and autism controversy in United Kingdom 1998–2005: Inevitable community outrage or a failure of risk communication? Vaccine, vol.24, p.3921–3928.
CASTRO, A. c (2004).Construindo Pontes: Inovações, Organizações e Estratégias como Abordagens Complementares. Revista Brasileira de Inovação, Rio de Janeiro, v. 3, n.2 Agos/Dez, p. 449-473.
CASSELL, J. A., LEACH, M., POLTORAK, M. S., MERCER, c. h., IVERSEN, A. &FAIRHEAD, J. r. (2006). Is the cultural context of MMR rejection a key to an effective public health discourse? Public Health 120(9): 783-794.
CASIDAY r, CRESSWELL T, WILSON D, PANTER-brIcK c. A survey of UK parental attitudes to the MMR vaccine and trust in medical authority. Vaccine, vol.24, p.177–84.
CASSIOLATTO, J; LASTRES, h (2005). Sistema de inovação e desenvolvimento as implicações de política, São Paulo Perspectivas, vol.19 no.1 Jan./Mar, 2005.
CHESBROUGH, h (2006). Open Innovation: the New Imperative for Creating and Profiting from Technology. Harvard Business School Press.
CHRISTENSEN, c (2000). The innovator´s dilemma. New York: Harper Business.
CORIAT, b. AnD WEISTEIN, o (2002). Organizations, Firms and Institutions in the Generation of Innovation. Research Policy 31, pp. 273-290.
COWAN, r; DAVID, P; FORAY, D (2000). The Explicit economics of Knowledge Codification and Tacitness, Industrial and Corporate Change, Vol. 9, No. 2, pp. 211-253.
DOSI, g; NELSON, r; WINTER, S (1999). Introduction, in Dosi, G., R. R. Nelson & S. G. Winter (Eds.), The Nature and Dynamics of Organizational Capabilities.Forthcoming, Oxford University Press, Oxford.
EIGEN, M (1997). O que restará da biologia do século XX? In Murphy & O’Neil (org). O que é vida? 50 anos depois: especulações sobre o futuro da Biologia. São Paulo: Unesp, 33.
EISENHARDT, K. M., & GRAEBNER, M. e. (2007). Theory Building From Cases: Opportunities and Challenges. Academy of Management Journal, 50(1), 8.
ELBE, S (2005). AIDS, Security, Biopolitics. International Relations, SAGE Publications.
ENGLAND (2007) Are we spending too much on HIV? BMJ, vol.334, p.334-344.
FEILDENBATTERSBY ANALYSTS (2005), The state of routine immunization services in Nigeria and reasons for current problems. Bath, UK: FBA Health Systems Analysts.
FITZPATRICK, M., 2004, MMR and Autism: What parents need to know. London: Routledge.
FREEMAN, c (1979). The determinants of innovation.Futures, June, 206-215, 1979.
FREEMAN, c (1987). Technology Policy and Economic Performance: Lessons from Japan, London, Frances Pinter.
FREEMAN, c; LOUCA, F (2001). As Time Goes By: From the Industrial Revolution to the Information Revolution. Oxford University Press: Oxford.
FREEMAN, c; PEREZ, c (1998). Structural Crises of Adjustment, Business Cycles and Investment Behavior., in Dosiet al (eds) Technical change and economic theory. London: Pinter, 1988.
FREEMAN, c; SOETE, L (2000).The economics of industrial innovation. Cambridge: The MIT Press.
FREEMAN, r; reeD, D (1984). Stockholders and Stakeholders: A new perspective on Corporate Governance. 3 ed. [S.l.]: California Management Review, Spring83, pp. 88-106. vol. 25.
GARRETT, L (2007). The challenge of global health. Foreign Affairs, 86: 14-38.
HARGREAVES, I., LEWIS, J. & SPEARS, T. (2002).Towards a better map: Science, the public and the media. Swindon: ESRC.
HODGSON, g (2005). ‘Institutions and Economic Development: Constraining, Enabling and Reconstituting’, in Dymski, G. and De Paula, S, Reimagining Growth: Towards a Renewal of Development Theory, (London and New York: Zed Books), pp.88-95.
HORTON r (2004). The lessons of MMR. Lancet; 363:747–9.
JASANOFF, S (2005).Designs on nature: science and democracy in England and the United States. Princenton: Princeton University Press.
JASANOFF, S (2009). Governing innovation. Paper presented at Knowledge in Question: a symposium on interrogating knowledge and questioning science, May 2009.
KLINE, S; ROSENBERG, n (1986). An Overview of Innovation, in Landau, R; Rosenberg, N.(orgs.),
The Positive Sum Strategy, Washington, DC: National Academy of Press, 1986.
FAIRHEAD, JAMES AnD LEACH, MeLISSA (2007) Vaccine Anxieties: Global Science, Child Health and Society. Science in Society, Taylor & Francis, London.
LeyDeSDorFF, L (2000). The triple helix: an evolutionary model of innovations. Research Policy, 29, 243–255.
LUNDVALL, b (1988). Innovation as an Interactive Process: From User-Producer Interaction to the National System of Innovation. In: Dosi, G et al(Ed.).Technical Change and Economic Theory. Londres: Pinter Publishers, p. 349-369.
LUNDVALL, b (1992) National systems of innovation: towards a theory of innovation and interactive learning. London: Pinter.
MALERBA, F (2004). Sectoral systems of innovation: basic concepts. In: Sectoral System of Innovation: Concepts, Issues and Analysis of Six Major Sectors in Europe, Malerba, F (Ed.). Cambridge University Press, Cambridge, pp. 9-41.
MILLSTONE, e (2007). Can food safety policy-making be both scientifically and democratically legitimated? If so how? Journal of Agricultural and Environmental Ethics, vol. 20, pp 483-508.
NELSON, r., SAMPAT, b (2001). Making Sense of Institutions as a Factor Shaping Economic Performance.Journal of Economic Behavior and Organization, 44, 31-54.
NELSON, r; WINTER, S (1982). An evolutionary theory of economic change. Cambridge, MA: Belknap Press.
PETTS J, NIEMEYER S (2004). Health risk communication and amplification: learning from the MMR vaccination controversy. Health Risk Soc, 6:7-23.
PORTER, M (1990). The competitive advantage of Nations. New York: Mcmillan.
RENNE, (2006). Perspectives on polio and immunization in Northern Nigeria. SocSci Med. 63(7):1857-69.
SCHUMPETER, J (1984). Capitalismo, socialismo e democracia: destruição criadora. Rio de Janeiro: Zahar.
SCHUMPETER, J. A (1982).Teoria do desenvolvimento econômico. São Paulo: Abril Cultural, 1982.
SOLOW, r (1956). A Contribution to the Theory of Economic Growth. Quarterly Journal of Economics, 70 (1): 65-94.
STIRLING, A (2007). Deliberate futures: Precaution and progress in social choice of sustainable technology. Sustainable Development 15:286-95.
TAVERNE, D. 2005.The march of unreason: Science, democracy and the new fundamentalism. Oxford, UK: Oxford University Press.
TEECE, D (1988). The Dynamic Capabilities of Firms: an Introduction, in Dosi, G; Teece, D., and Chytry, J – Technology, Organization, and Competitiveness: Perspectives on Industrial and Corporate Change, Oxford University Press, pgs. 193 a 214.
TIDD, J (2001). Innovation management in context: environment, organization and performance. International Journal of Management Review, 3(3), 169–83.
VAN De VEN, A (1986). Central problems in management of innovation. Management Science,
Vol 32, No 5.
VIOTTI, e (2002). National Learning Systems: A new approach on technological change in late industrializing economies and evidences from the cases of Brazil and South Korea, Technological Forecasting and Social Change, Vol 69, pp. 653-680.
von HIPPEL, e (2001). Perspective: User toolkits for innovation. Journal of Product Innovation Management, 18(4), 247-257, 2001.
WAKEFIELD A, MURCH S, AnThony A, LINNELL J, CASSON D, MALIK M, et al (1998). Ileal- lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet; 351:637-41.
WHO (2003). Global Polio Eradication Initiative Progress 2002.Polio 03/02, Geneva, Switzerland.
YAHYA, M (2007). Polio vaccines: ‘No thank you!’ Barriers to polio eradication in Northern Nigeria, African Affairs 106/423 (2007), pp. 185-204.
YIN, r (2009). Case Study Research: Design and Methods. Fourth Edition. SAGE Publications. California, 2009.
